CY1110572T1 - Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης - Google Patents
Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασηςInfo
- Publication number
- CY1110572T1 CY1110572T1 CY20091101244T CY091101244T CY1110572T1 CY 1110572 T1 CY1110572 T1 CY 1110572T1 CY 20091101244 T CY20091101244 T CY 20091101244T CY 091101244 T CY091101244 T CY 091101244T CY 1110572 T1 CY1110572 T1 CY 1110572T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antagonists
- acid
- antidepressant
- sulic
- acsyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Στοματικό αντικαταθλιπτικό σκεύασμα το οποίο περιλαμβάνει μια αποτελεσματική αντικαταθλιπτική ποσότητα ενός ή περισσότερων φαρμακευτικώς αποδεκτών αντικαταθλιπτικών δραστικών παραγόντων πλεονεκτικά επιλεγμένων από την ομάδα η οποία αποτελείται από SSRIs, SNRIs (αναστολείς επαναπρόσληψης σεροτονίνης νοραδρεναλίνης) CRF ανταγωνιστές, ΝΚ1 ανταγωνιστές, ΝΚ2 ανταγωνιστές, ΝΚ3 ανταγωνιστές και συνδυασμούς αυτών, και μια αποτελεσματική ποσότητα μικρότερη από 50 mg τουλάχιστον μίας ένωσης επιλεγμένης από την ομάδα η οποία αποτελείται από ακετυλοσαλικυλικό οξύ, παράγωγα του ακετυλοσαλικυλικού οξέος, και μείγματα αυτών, για μείωση του χρόνου έναρξης αντικαταθλιπτικής δράσης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BE2003/000181 WO2005039545A1 (en) | 2003-10-29 | 2003-10-29 | Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action |
EP03770801A EP1677772B1 (en) | 2003-10-29 | 2003-10-29 | Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110572T1 true CY1110572T1 (el) | 2015-04-29 |
Family
ID=34468654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20091101244T CY1110572T1 (el) | 2003-10-29 | 2009-11-26 | Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1677772B1 (el) |
JP (1) | JP2007509838A (el) |
CN (1) | CN1859901A (el) |
AT (1) | ATE440597T1 (el) |
AU (1) | AU2003280232A1 (el) |
BR (1) | BR0318586A (el) |
CA (1) | CA2543640C (el) |
CY (1) | CY1110572T1 (el) |
DE (1) | DE60329034D1 (el) |
DK (1) | DK1677772T3 (el) |
EA (1) | EA011926B1 (el) |
ES (1) | ES2332176T3 (el) |
PT (1) | PT1677772E (el) |
SI (1) | SI1677772T1 (el) |
WO (1) | WO2005039545A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100189797A1 (en) * | 2002-06-10 | 2010-07-29 | Julien Mendlewicz | Oral antidepressant formulation |
IT1392333B1 (it) * | 2008-12-16 | 2012-02-28 | Giofarma S R L | Preparazione farmaceutica per il trattamento di patologie depressive, contenente una proteina con elevato rapporto triptofano/lnaa |
GB201002530D0 (en) | 2010-02-15 | 2010-03-31 | Univ Wolverhampton The | Di-aspirin derivatives |
CN112438991B (zh) * | 2019-08-29 | 2024-03-15 | 鲁南制药集团股份有限公司 | 肝素、或其衍生物、或其可药用盐的医药用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4650789A (en) * | 1985-10-15 | 1987-03-17 | Commonwealth Medical Corporation Of America | Method and composition for increasing production of serotonin |
GB2287404A (en) * | 1994-03-15 | 1995-09-20 | Pfizer | Antiinflammatory and analgesic compositions |
AU1718400A (en) * | 1998-11-13 | 2000-06-05 | Eli Lilly And Company | Method for treating pain |
EP1165083A2 (en) * | 1999-04-06 | 2002-01-02 | Sepracor Inc. | Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |
US6432989B1 (en) * | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
WO2003103643A1 (en) * | 2002-06-10 | 2003-12-18 | Philippe Kriwin | Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor |
-
2003
- 2003-10-29 BR BRPI0318586-9A patent/BR0318586A/pt not_active IP Right Cessation
- 2003-10-29 ES ES03770801T patent/ES2332176T3/es not_active Expired - Lifetime
- 2003-10-29 JP JP2005509765A patent/JP2007509838A/ja active Pending
- 2003-10-29 EA EA200600834A patent/EA011926B1/ru not_active IP Right Cessation
- 2003-10-29 DE DE60329034T patent/DE60329034D1/de not_active Expired - Lifetime
- 2003-10-29 DK DK03770801T patent/DK1677772T3/da active
- 2003-10-29 PT PT03770801T patent/PT1677772E/pt unknown
- 2003-10-29 CA CA2543640A patent/CA2543640C/en not_active Expired - Fee Related
- 2003-10-29 CN CNA2003801106380A patent/CN1859901A/zh active Pending
- 2003-10-29 AT AT03770801T patent/ATE440597T1/de active
- 2003-10-29 EP EP03770801A patent/EP1677772B1/en not_active Expired - Lifetime
- 2003-10-29 WO PCT/BE2003/000181 patent/WO2005039545A1/en active Application Filing
- 2003-10-29 AU AU2003280232A patent/AU2003280232A1/en not_active Abandoned
- 2003-10-29 SI SI200331701T patent/SI1677772T1/sl unknown
-
2009
- 2009-11-26 CY CY20091101244T patent/CY1110572T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE60329034D1 (de) | 2009-10-08 |
EA200600834A1 (ru) | 2006-10-27 |
DK1677772T3 (da) | 2009-12-21 |
EP1677772A1 (en) | 2006-07-12 |
CA2543640C (en) | 2010-06-01 |
EA011926B1 (ru) | 2009-06-30 |
ES2332176T3 (es) | 2010-01-28 |
CN1859901A (zh) | 2006-11-08 |
BR0318586A (pt) | 2006-10-17 |
ATE440597T1 (de) | 2009-09-15 |
JP2007509838A (ja) | 2007-04-19 |
SI1677772T1 (sl) | 2010-01-29 |
WO2005039545A1 (en) | 2005-05-06 |
AU2003280232A1 (en) | 2005-05-11 |
CA2543640A1 (en) | 2005-05-06 |
PT1677772E (pt) | 2009-11-26 |
EP1677772B1 (en) | 2009-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8546601A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
ATE406360T1 (de) | Antagonisten der opioidrezeptoren | |
MXPA04000456A (es) | Analogos de prostaglandina como agonistas del receptor ep4. | |
HRP20080666T3 (en) | Cgrp receptor antagonists | |
EA199800140A1 (ru) | Композиции с контролируемым высвобождением пароксетина | |
DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
ATE308522T1 (de) | Opioidrezeptorantagonisten | |
DE60324544D1 (de) | Muskarin antagonisten | |
DE69903333T2 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
EA200400280A1 (ru) | Новые неочищенные и кристаллические формы гидрохлорида лерканидипина | |
CY1110572T1 (el) | Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης | |
TW200508195A (en) | 3-aminopyrrolidines as inhibitors of monoamine uptake | |
EA200501697A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
NO20014855L (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
PT1204658E (pt) | Agonistas benzofurilpiperazina de serotonina | |
NO20035148D0 (no) | Tri- og tetra-aza-acenaftylenderivater som CRF- reseptorantagonister | |
EA200500672A1 (ru) | Содержащие альфузозин композиции с отсроченным высвобождением | |
EA200400279A1 (ru) | Сольваты гидрохлорида лерканидипина и новые кристаллические формы гидрохлорида лерканидипина, полученные из указанных сольватов | |
ATE250058T1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
DE60102231D1 (de) | Crf rezeptor-antagonisten und darauf bezogene methoden | |
WO2003103643A8 (en) | ANTI-DEPRESSIVE ORAL ADMINISTRATION FORMULATION CONTAINING A SELECTIVE SEROTONIN REABSORPTION INHIBITOR | |
EA200401617A1 (ru) | Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера | |
ECSP034870A (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 |